The main findings of the present study were that in patients with astrocytoma, FMRP expression was associated with higher pathologic grade, faster proliferation (assessed from Ki67 expression), larger tumor size and shorter survival. Here, FMR1 is linked to astrocytoma (excluding glioblastoma).